AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6508263 — intervention group
Group type: COMPARATOR
Intervention: Comparative agents (piperacillin or moxalactam)
Number of subjects: 116
Study 6508263 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin
Number of subjects: 116
Study 6508263 — intervention group
Group type: COMPARATOR
Intervention: Moxalactam
Number of subjects: 116
Study 6508263 — intervention group
Group type: EXPERIMENTAL
Intervention: Timentin
Number of subjects: 116
Study 31157962 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy (tamoxifen alone)
Number of subjects: 9427
Study 31157962 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoendocrine therapy
Number of subjects: 9427
Study 28724815 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral mydriatic solution
Number of subjects: 127
Study 28724815 — intervention group
Group type: COMPARATOR
Intervention: Topical mydriatics
Number of subjects: 127
Study 27033859 — intervention group
Group type: EXPERIMENTAL
Intervention: BIOSCIENCE trial participants
Number of subjects: 1216
Study 27033859 — intervention group
Group type: COMPARATOR
Intervention: Non-participants from the CARDIOBASE registry
Number of subjects: 1216
Study 25078879 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypothermia at 33°C (n = 11)
Number of subjects: 20
Study 25078879 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypothermia at 36°C (n = 9)
Number of subjects: 20
Study 25078879 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study 22999400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal administration of 10mg of 0.5% hyperbaric bupivacaine combined with 80 mcg of morphine and 2.5 mcg of sufentanil
Number of subjects: 80
Study 22999400 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving 10mg of 0.5% hyperbaric bupivacaine combined with 80 mcg of morphine
Number of subjects: 80
Study 22999400 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 19398784 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 175
Study 19398784 — intervention group
Group type: EXPERIMENTAL
Intervention: Danaproid sodium
Number of subjects: 175
Study 19398784 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 175
Study 17488312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 1 mg/kg (Group K1)
Number of subjects: 120
Study 17488312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 2 mg/kg (Group K2)
Number of subjects: 120
Study 17488312 — intervention group
Group type: COMPARATOR
Intervention: Propofol 3 mg/kg (Group P)
Number of subjects: 120
Study 15034949 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole (BZ) with Thioctic Acid (TA) at daily doses of 50 to 100 mg for 30 days
Number of subjects: 249
Study 15034949 — intervention group
Group type: COMPARATOR
Intervention: Benznidazole (BZ)
Number of subjects: 249
Study 11062321 — intervention group
Group type: EXPERIMENTAL
Intervention: Categorized objects
Number of subjects: 0
Study 11062321 — intervention group
Group type: COMPARATOR
Intervention: Neutral object
Number of subjects: 0
Study 9630294 — intervention group
Group type: EXPERIMENTAL
Intervention: Full standardized dose of laser (40 x 1500 mW for 1500 ms)
Number of subjects: 30
Study 9630294 — intervention group
Group type: EXPERIMENTAL
Intervention: Half standardized dose of laser (40 x 750 mW for 1500 ms)
Number of subjects: 30
Study 9630294 — intervention group
Group type: EXPERIMENTAL
Intervention: Full treatment subgroup with neovascular glaucoma
Number of subjects: 30
Study 9630294 — intervention group
Group type: EXPERIMENTAL
Intervention: Sighted eyes
Number of subjects: 30
Study 9630294 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind eyes
Number of subjects: 30
Study 9630294 — intervention group
Group type: COMPARATOR
Intervention: Postoperative inflammation
Number of subjects: 30
Study 7983235 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 50 mg once a day
Number of subjects: 0
Study 7983235 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine retard 20 mg twice a day
Number of subjects: 0
Study 2512486 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric protein‐restricted diet (0.4 g of protein per kilogram of body weight per day)
Number of subjects: 64
Study 2512486 — intervention group
Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 64
Study 2512486 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein‐restricted diet
Number of subjects: 64
Study 30596538 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Information Package Program (HIPP) - video presentation and PowerPoint slides
Number of subjects: 200
Study 30596538 — intervention group
Group type: COMPARATOR
Intervention: Standard care in antenatal clinics (including iron supplementation)
Number of subjects: 200
Study 28104250 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab 150mg subcutaneous every 4 weeks
Number of subjects: 0
Study 28104250 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta-1a 30mcg intramuscular once weekly
Number of subjects: 0
Study 26113419 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg twice daily
Number of subjects: 73
Study 22765642 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel brackets
Number of subjects: 32
Study 22765642 — intervention group
Group type: COMPARATOR
Intervention: Esthetic brackets
Number of subjects: 32
Study 21777736 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of fipronil, amitraz and (S)-methoprene (CERTIFECT™) at 28 days prior to tick infestation.
Number of subjects: 32
Study 21777736 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of fipronil, amitraz and (S)-methoprene (CERTIFECT™) at 21 days prior to tick infestation.
Number of subjects: 32
Study 21777736 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of fipronil, amitraz and (S)-methoprene (CERTIFECT™) at 14 days prior to tick infestation.
Number of subjects: 32
Study 21777736 — intervention group
Group type: COMPARATOR
Intervention: Control group (not treated).
Number of subjects: 32
Study 19433838 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal cancer screening (including CA-125 tests, transvaginal sonograms, chest radiographs, flexible sigmoidoscopies, digital rectal examinations, and serum PSA tests)
Number of subjects: 68436
Study 19433838 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal cancer screening
Number of subjects: 68436
Study 16618834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg daily
Number of subjects: 28
Study 16618834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 12510011 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day for 12 weeks
Number of subjects: 120
Study 12510011 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 120
Study 12510011 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 120
Study 11045914 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose PGE1 (2.5 - 5.0 microg)
Number of subjects: 50
Study 11045914 — intervention group
Group type: COMPARATOR
Intervention: Standard sex therapy for twelve weeks
Number of subjects: 50
Study 9200991 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 31
Study 9200991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 1552056 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin emollient cream 0.05%
Number of subjects: 296
Study 1552056 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 296
Study 1552056 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin emollient cream 0.01%
Number of subjects: 296
Study 1552056 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin emollient cream 0.001%
Number of subjects: 296
Study 3886304 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg brompheniramine maleate
Number of subjects: 24
Study 3886304 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg clemastine fumarate
Number of subjects: 24
Study 3886304 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 29401075 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum Elastic Bougie (GEB)
Number of subjects: 110
Study 29401075 — intervention group
Group type: COMPARATOR
Intervention: Routine intubation without GEB
Number of subjects: 110
Study 29401075 — intervention group
Group type: EXPERIMENTAL
Intervention: GEB
Number of subjects: 110
Study 27363400 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored patient-activation DXA result letter and educational brochure
Number of subjects: 7749
Study 27363400 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 7749
Study 25345961 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular apical (RVA) pacing
Number of subjects: 60
Study 25345961 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular outflow tract (RVOT) pacing
Number of subjects: 60
Study 24354588 — intervention group
Group type: COMPARATOR
Intervention: 13-valent conjugated pneumococcal vaccine
Number of subjects: 600
Study 24354588 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare and non-healthcare resources use, quality-of-life (using EQ-5D and SF-36 questionnaires)
Number of subjects: 600
Study 24354588 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-pocket costs of patients and productivity losses of both patients and their caregivers
Number of subjects: 600
Study 20090057 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipatory and Preventive Team Care (APTCare)
Number of subjects: 152
Study 20090057 — intervention group
Group type: COMPARATOR
Intervention: Usual care from family physicians
Number of subjects: 152
Study 18947290 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching primer (SEP) - Transbond Plus
Number of subjects: 39
Study 18947290 — intervention group
Group type: COMPARATOR
Intervention: Conventional two-step etch and primer method (CM) - Transbond XT
Number of subjects: 39
Study 18947290 — intervention group
Group type: COMPARATOR
Intervention: Comparison of bonding procedures
Number of subjects: 39
Study 18947290 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of tooth (incisor, canine, premolar)
Number of subjects: 39
Study 18947290 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper and lower dental arches
Number of subjects: 39
Study 18947290 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients' gender
Number of subjects: 39
Study 18947290 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive Remnant Index (ARI) scores
Number of subjects: 39
Study 17444097 — intervention group
Group type: EXPERIMENTAL
Intervention: Microincision cataract surgery
Number of subjects: 60
Study 17444097 — intervention group
Group type: COMPARATOR
Intervention: Small incision cataract surgery
Number of subjects: 60
Study 14672301 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based dietary diversification/modification intervention
Number of subjects: 0
Study 14672301 — intervention group
Group type: COMPARATOR
Intervention: Control diets
Number of subjects: 0
Study 10090927 — intervention group
Group type: EXPERIMENTAL
Intervention: Busulfan 16 mg/kg
Number of subjects: 167
Study 10090927 — intervention group
Group type: COMPARATOR
Intervention: Total Body Irradiation (TBI)
Number of subjects: 167
Study 7884425 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (100 mg/m2 intravenously over 1 hour every 3 weeks)
Number of subjects: 44
Study 2206058 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine dorsal penile nerve block
Number of subjects: 51
Study 2206058 — intervention group
Group type: COMPARATOR
Intervention: Saline solution injections
Number of subjects: 51
Study 2206058 — intervention group
Group type: COMPARATOR
Intervention: No injections
Number of subjects: 51
Study 6108392 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (2 doses of 40 micrograms)
Number of subjects: 100
Study 6108392 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccine (3 doses of 40 micrograms)
Number of subjects: 100
Study 6108392 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose of Hepatitis B vaccine
Number of subjects: 100
Study 6108392 — intervention group
Group type: EXPERIMENTAL
Intervention: Male patients
Number of subjects: 100
Study 31216729 — intervention group
Group type: EXPERIMENTAL
Intervention: Random decision forests
Number of subjects: 0
Study 31216729 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradient boosting
Number of subjects: 0
Study 31216729 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremely randomized trees
Number of subjects: 0
Study 31216729 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive boosting
Number of subjects: 0
Study 31216729 — intervention group
Group type: EXPERIMENTAL
Intervention: K‐nearest neighbors
Number of subjects: 0
Study 31216729 — intervention group
Group type: EXPERIMENTAL
Intervention: Shallow neural networks
Number of subjects: 0
Study 28747328 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent low-energy diet (LED) for 5 weeks every 4 months for 3 years
Number of subjects: 153
Study 28747328 — intervention group
Group type: COMPARATOR
Intervention: Daily meal replacements of 1-2 meals for 3 years
Number of subjects: 153
Study 24877791 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking about stories of difficulty (treatment)
Number of subjects: 49
Study 24877791 — intervention group
Group type: COMPARATOR
Intervention: Daily events (control)
Number of subjects: 49
Study 23906400 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose L-amlodipine besylate (2.5 mg/d)
Number of subjects: 1051
Study 23906400 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose L-amlodipine besylate (5.0 mg/d)
Number of subjects: 1051
Study 23906400 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine maleate (5.0 mg/d)
Number of subjects: 1051
Study 21434781 — intervention group
Group type: EXPERIMENTAL
Intervention: TM tibial components fixed press-fit by 2 hexagonal pegs
Number of subjects: 50
Study 21434781 — intervention group
Group type: COMPARATOR
Intervention: Ti tibial components fixed press-fit and by 4 supplemental screws
Number of subjects: 50
Study 19595142 — intervention group
Group type: EXPERIMENTAL
Intervention: T0901317, 9‐cis retinoic acid, chenodeoxycholic acid (CDCA) - agonists of LXR, RXR, FXR
Number of subjects: 41
Study 19595142 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallbladder mucosa from GS patients
Number of subjects: 41
Study 19595142 — intervention group
Group type: COMPARATOR
Intervention: Gallbladder mucosa from GSF patients
Number of subjects: 41
Study 16563905 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg twice daily
Number of subjects: 33
Study 16563905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 12740281 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine chest radiographs (CXRs)
Number of subjects: 94
Study 12740281 — intervention group
Group type: COMPARATOR
Intervention: Nonroutine chest radiographs (CXRs)
Number of subjects: 94
Study 11267622 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (21 mg/24 h)
Number of subjects: 32
Study 11267622 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (42 mg/24 h)
Number of subjects: 32
Study 11267622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mecamylamine (10 mg)
Number of subjects: 32
Study 11267622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 9675383 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural/propofol anesthesia (Group P)
Number of subjects: 23
Study 9675383 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural/midazolam anesthesia (Group M)
Number of subjects: 23
Study 9675383 — intervention group
Group type: COMPARATOR
Intervention: Epidural/sevoflurane anesthesia (Group S)
Number of subjects: 23
Study 7860158 — intervention group
Group type: EXPERIMENTAL
Intervention: AIK-C (medium- and standard-titre)
Number of subjects: 2452
Study 7860158 — intervention group
Group type: EXPERIMENTAL
Intervention: Edmonston-Zagreb (EZ)
Number of subjects: 2452
Study 7860158 — intervention group
Group type: EXPERIMENTAL
Intervention: Leningrad-16
Number of subjects: 2452
Study 7860158 — intervention group
Group type: EXPERIMENTAL
Intervention: Schwarz
Number of subjects: 2452
Study 7860158 — intervention group
Group type: EXPERIMENTAL
Intervention: All strains of measles vaccine
Number of subjects: 2452
Study 7860158 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 2452
Study 2680162 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg/day methylprednisolone for 3 days
Number of subjects: 128
Study 2680162 — intervention group
Group type: COMPARATOR
Intervention: 1,000 mg/day methylprednisolone for 3 days
Number of subjects: 128
Study 788430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg
Number of subjects: 25
Study 788430 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.0 mg
Number of subjects: 25
Study 788430 — intervention group
Group type: COMPARATOR
Intervention: Control insulin tolerance test
Number of subjects: 25
Study 6167516 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 450/0.7
Number of subjects: 20
Study 6167516 — intervention group
Group type: COMPARATOR
Intervention: 5% human albumin
Number of subjects: 20
Study 30678028 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour water-only fasting
Number of subjects: 0
Study 30678028 — intervention group
Group type: COMPARATOR
Intervention: 24-hour ad libitum fed day
Number of subjects: 0
Study 28843486 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based multimedia curriculum (6 self-paced, interactive modules)
Number of subjects: 442
Study 28843486 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based multimedia curriculum (modules)
Number of subjects: 442
Study 28843486 — intervention group
Group type: COMPARATOR
Intervention: Readings (control curriculum)
Number of subjects: 442
Study 28843486 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based multimedia curriculum (verbal handoff virtual simulation)
Number of subjects: 442
Study 28843486 — intervention group
Group type: EXPERIMENTAL
Intervention: Device-related emergency virtual simulation
Number of subjects: 442
Study 26766905 — intervention group
Group type: EXPERIMENTAL
Intervention: Dumbbell-training group (DTG)
Number of subjects: 45
Study 26766905 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 45
Study 24742740 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent loaded with (125)iodine radioactive seeds (irradiation group)
Number of subjects: 160
Study 24742740 — intervention group
Group type: COMPARATOR
Intervention: Conventional oesophageal stent (control group)
Number of subjects: 160
Study 23234491 — intervention group
Group type: EXPERIMENTAL
Intervention: Ditto™ intervention group (receiving Ditto™, procedural preparation and Ditto™ distraction)
Number of subjects: 58
Study 23234491 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard distraction)
Number of subjects: 58
Study 19912196 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP (potassium-titanyl-phosphate Greenlight 80-W laser ablation system)
Number of subjects: 120
Study 19912196 — intervention group
Group type: COMPARATOR
Intervention: TURP (transurethral resection of the prostate)
Number of subjects: 120
Study 19912196 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP
Number of subjects: 120
Study 19912196 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 120
Study 17622003 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable collagen barriers supported by osteosynthesis plates
Number of subjects: 22
Study 17622003 — intervention group
Group type: COMPARATOR
Intervention: Nonresorbable titanium-reinforced e-PTFE barrier
Number of subjects: 22
Study 15862370 — intervention group
Group type: EXPERIMENTAL
Intervention: Becker plus figure-of-eight supplementary core suture
Number of subjects: 45
Study 15862370 — intervention group
Group type: EXPERIMENTAL
Intervention: Becker plus anchor supplementary core suture
Number of subjects: 45
Study 15862370 — intervention group
Group type: COMPARATOR
Intervention: Becker only
Number of subjects: 45
Study 12232886 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training
Number of subjects: 134
Study 12232886 — intervention group
Group type: COMPARATOR
Intervention: Bladder training
Number of subjects: 134
Study 10211919 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg/day, flexible titration up to 200 mg/day)
Number of subjects: 167
Study 10211919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 7892513 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary factors (vitamin C and alcohol consumption)
Number of subjects: 175
Study 2223140 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple mastectomy with postoperative x-ray treatment
Number of subjects: 0
Study 2223140 — intervention group
Group type: COMPARATOR
Intervention: Extended radical mastectomy
Number of subjects: 0
Study 2223140 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological grading (grade 1 tumours)
Number of subjects: 0
Study 2223140 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological grading (grades 2 and 3 tumours)
Number of subjects: 0
Study 2223140 — intervention group
Group type: EXPERIMENTAL
Intervention: Node positive patients
Number of subjects: 0
Study 2223140 — intervention group
Group type: EXPERIMENTAL
Intervention: Node negative patients
Number of subjects: 0
Study 2223140 — intervention group
Group type: EXPERIMENTAL
Intervention: Premenopausal women
Number of subjects: 0
Study 655230 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide Sequels
Number of subjects: 0
Study 655230 — intervention group
Group type: EXPERIMENTAL
Intervention: Methazolamide
Number of subjects: 0
Study 655230 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethoxzolamide
Number of subjects: 0
Study 655230 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide tablets
Number of subjects: 0
Study 655230 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichlorphenamide
Number of subjects: 0
Study 655230 — intervention group
Group type: COMPARATOR
Intervention: Ascorbic acid placebo
Number of subjects: 0
Study 31179339 — intervention group
Group type: EXPERIMENTAL
Intervention: Baoshenfang Formula (BSF)
Number of subjects: 0